Post-testicular sperm maturation requires a specific luminal environment in the epididymis that is created, in part, by the blood-epididymis barrier. There is limited information on gene expression in the epididymis of infertile obstructive azoospermia (OA) patients due to the difficulty in obtaining tissues. The objectives of this study were to determine if epididymal tight junction proteins are altered in OA and to develop cell lines that could serve to elucidate alterations in the epididymis of infertile men. Epididymal claudin (CLDN) 1, CLDN4, and CLDN10 mRNA levels were altered in OA downstream from the obstruction site. Epithelial cell lines derived from the caput epididymidis of one OA patient were developed (infertile human caput epididymal cell line [IHCE]). IHCEs were composed of homogenous populations of diploid cells that ultrastructurally resembled in vivo principal cells. The cells expressed cytokeratin, SPAG11B, CLDN2, CLDN3, desmoplakin, and vimentin.
INTRODUCTION
Between 40% and 50% of infertile couples are unable to conceive after 1 yr of unprotected intercourse due to male factor infertility [1, 2] . In approximately 25% of these cases, the cause of infertility is unknown and is likely associated with multiple causes [3] . Azoospermia, defined as the absence of spermatozoa in the ejaculate, occurs in 10%-15% of infertile men. In approximately 40% of cases, azoospermia is due to an obstruction of the ductal system. These can occur as a result of congenital defects, or they may be acquired [4, 5] . Advances in the treatment of male infertility allow OA patients to father children using microsurgical reconstruction or surgical retrieval of sperm for intracytoplasmic sperm injection (ICSI) if reconstruction has failed or is impossible [6] . For epididymal obstruction, even if microsurgical reconstruction with epididymovasostomy is successful (patency rates range from 46% to 81%), natural pregnancy rates are low (13%-44%) [7] , especially in cases of primary epididymal obstruction unrelated to vasectomy [8] . Higher pregnancy rates ranging from 24% to 64% have been observed for OA patients using ICSI [5, 9, 10] . ICSI can be achieved with epididymal sperm or, if the epididymis is inaccessible or no motile sperm can be retrieved, with testicular sperm [11] . However, higher miscarriage rates and lower pregnancy rates occur when testicular sperm are used instead of epididymal sperm [12, 13] . It has also been observed that the use of epididymal sperm, in cases of acquired obstruction compared with congenital bilateral absence of vas deferens, results in lower embryo quality and pregnancy rates [12] . Furthermore, the production of antisperm antibodies has been associated with obstructive azoospermia (OA) [14] . Antisperm antibodies may be produced when the blood-testis or blood-epididymis barrier is compromised. Previous investigations have demonstrated that defects in the bloodepididymis barrier may be associated with altered sperm motility or with non-OA [15] .
Epididymal sperm maturation, which is essential for the acquisition of progressive motility and the ability to fertilize [16, 17] , depends on the unique luminal environment created by the secretion and absorption of proteins and ions by the epithelium and the selective transport of molecules across the blood-epididymis barrier [18] [19] [20] . The blood-epididymis barrier also contributes to the protection of sperm from the immune system [21] . This barrier comprises apical tight junctions between principal cells that create a seal between the cells and forces the selective transport of molecules across the epithelium.
Tight junctions are composed of integral proteins such as occludin (OCLN), tricellulin, and a larger family of proteins, the claudins (CLDNs) [22, 23] . It has previously been reported that the rat and human epididymis contain a large number of CLDNs [24] [25] [26] [27] [28] . The combination of CLDNs determines the selective permeability of the barrier [29] . Tight junctions also include peripheral membrane proteins such as TJP1, TJP2, and TJP3. The formation of tight junctions involves adherens junctions, which initiate and maintain intercellular adhesion to permit the formation of other types of junctions [30] . Adherens junctions consist of two multiprotein complexes, the nectinafadin complex and the cadherin-catenin complex [31] . Several cadherins and catenins are expressed in the rat and human epididymis [24, 32, 33] .
The reduced fertility in patients following epididymovasostomy may result from antisperm antibodies or epididymal dysfunction. It is therefore important to understand these pathologies and their consequences for the epididymis in order to develop new strategies for the treatment of infertility resulting from OA. The creation of new biological tools is a crucial step toward understanding the causes of male infertility. In the present study, we have identified several defects in the blood-epididymis barrier of OA patients by using novel human epididymal cell lines to study the molecular and cellular mechanisms responsible for these defects.
MATERIALS AND METHODS

Patients
Epididymal tissues were obtained from patients with active spermatogenesis (n ¼ 5) undergoing radical orchidectomy for localized testicular cancer (confined within the testicular tunica albuginea with no sign of epididymal lesion or obstruction) or OA patients (n ¼ 5) undergoing vasoepididymostomy after informed consent was given. The mean patient age was 29.6 yr (age range, 20-43 yr). Serum follicle-stimulating hormone (IU/L), luteinizing hormone (IU/L), testosterone (nmol/L), and estradiol (pmol/L) levels, when available, were reviewed using medical records of the patients to demonstrate that patients had comparable physiological parameters ( Table 1 ). The study was conducted 
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with the approval of the McGill University ethics committee for research on human subjects.
Tissue Preparation
For OA patients, at the time of microsurgical epididymovasostomy, a small piece of epididymis was taken distally adjacent to the obstruction site. Epididymal tissue was placed in cold culture medium (Dulbecco modified Eagle medium [DMEM]/HAM F12 culture medium containing 2 mM glutamine, 50 U/ml of penicillin, and 50 lg/ml of streptomycin; SigmaAldrich, Mississauga, ON) and processed under aseptic conditions within 1 h of surgery. Epididymides were divided into three segments, the caput, corpus, and cauda epididymidis (see Dubé et al. [15] for a schematic representation of the different human epididymal segments). Obstructions were situated at the level of the caput or the corpus epididymidis (Table 1) .
Real-Time RT-PCR
Real-time RT-PCR was used to assess the expression of several genes encoding junctional proteins in the epididymis of OA patients (n ¼ 3; patients 3À5 in Table 1 ). Total RNA (500 ng) was reverse transcribed using an oligo(dT)16 primer (R&D Systems Inc., Minneapolis, MN). Primers are listed in Table 2 . Real-time RT-PCR was performed with a Rotor-Gene RG 3000 (Corbett Research, Sydney, Australia) in duplicate. A 2-ll aliquot of the RT reaction was amplified in a 15-ll solution that contained 13 PerfeCTa SYBR Green SuperMix (Quanta Biosciences Inc., Gaithersburg, MD) and 200 nM of each of the reverse and forward primers. The PCR cycling protocols were optimized to maximize reaction efficiency and to ensure that only the target product contributed to the SYBR Green fluorescence signal. For each analysis, a standard curve was created using the appropriate cDNA. Amplifications consisted of 40 cycles at 958C for 15 sec, melting temperature for 30 sec, and 728C for 30 sec. Following PCR amplification, melting curve analysis was performed to ensure the accuracy of the quantification primers. The housekeeping genes (ACTB or GAPDH) were used to normalize the values for each sample. Statistical analyses were performed with one-way ANOVA (significance level set at P 0.05).
Immunohistochemistry
Small pieces of epididymal tissue from fertile (n ¼ 3) and OA (n ¼ 4) patients were fixed at the time of surgery by immersion in Bouin fixative (Fisher Scientific, Ottawa, ON) for 24 h, dehydrated, and embedded in paraffin. Thick sections (5 lm) were cut and mounted on glass slides. For immunostaining, the tissue sections were rehydrated through graded ethanol, including 70% alcohol with 1% lithium carbonate for 5 min, to remove residual picric acid. The sections were then incubated in 300 mM glycine for 5 min to block free aldehydes and washed in PBS (137 mM NaCl, 2. 
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performed by boiling the slides for 10 min in citrate buffer (1.8 mM citric acid and 8.2 mM sodium citrate). Immunolocalization was performed with the DAKO Catalyzed Signal Amplification System (DAKO, Carpenteria, CA). The primary antibodies used in this study were a rabbit polyclonal anti-CDH1 (0.483 lg/ml; Cell Signaling, Danvers, MA), a rabbit polyclonal anti-TJP1 (0.25 lg/ml; Invitrogen Inc., Burlington, ON), and a mouse monoclonal antivimentin (anti-VIM) (1 lg/ml; Abcam, Cambridge, MA). Primary antibodies were incubated for 60 min at room temperature (CDH1 and TJP1) or overnight at 48C (VIM). Omission of primary antibodies, as well as rabbit serum or mouse normal IgG, served as negative controls. Epididymal sections were counterstained for 5 min with 0.1% methylene blue, dehydrated in ethanol, immersed in Histoclear (Fisher Scientific), and mounted in Permount (Fisher Scientific). Sections were examined under a Leica (Wetzlar, Germany) DMRE microscope.
Primary Cell Culture
Human epididymal cells were isolated from the caput epididymidis of patient 10 ( Table 1 ) according to the methods by Dufresne et al. [34] . Briefly, tissue fragments (2-3 mm 3 ) were placed in DMEM/HAM F12 culture medium containing 2 mM glutamine, 50 U/ml of penicillin, 50 lg/ml of streptomycin, 2 mg/ml of collagenase (Life Technologies, Inc., Burlington, ON), and 20 U/ml of DNase (Promega, Ottawa, ON). Tissue fragments were dissociated by successive enzymatic digestions for 50 min in a shaking water bath at 378C with gentle repetitive pipetting, followed by medium replacement between digestions. At the end of the final digestion, the cells were centrifuged (34 3 g) for 3 min, and the pellet was resuspended in DMEM/HAM F12 culture medium containing antibiotics and nutrients (50 U/ml of penicillin, 50 lg/ml of streptomycin, 2 mM L-glutamine, 10 lg/ml of insulin, 10 lg/ml of transferrin, 80 ng/ml of hydrocortisone, 5 nM testosterone, 10 ng/ml of epidermal growth factor, 10 ng/ml of cAMP, 2 ng/ml of sodium selenium, 200 ng/ml of tocopherol, 200 ng/ml of retinol, and 1% fetal bovine serum [FBS] [SigmaAldrich]). The small tissue fragments were then placed in cell culture plates coated with collagen IV (BD Biosciences, Mississauga, ON) and incubated in a humidified chamber at 328C with 5% CO 2 . The culture medium was changed every 48 h until 40%À50% confluence was reached.
Immortalization of Epididymal Cells
Primary culture cells were transfected with a pBK-CMV plasmid containing the SV40 LTAg and neomycin resistance genes (a kind gift of Dr. D. W. Silversides, University of Montreal, Montreal, QC) by calcium phosphate precipitation as described by Dufresne et al. [34] . Stable transfectants were then selected using neomycin (200 lg/ml ofG418; GIBCO BRL, Burlington, ON) in the culture media for 14 days, and cells were isolated by serial dilution to generate different stable cell lines. Medium containing 10% FBS was changed every 48 h.
Electron Microscopy
Immortalized cells were either trypsinized (0.05% trypsin and 0.53 mM edetic acid) and collected by centrifugation (300 3 g) or grown on plastic chamber slides (Nalge Nunc International, Naperville, IL) and fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer for 24 h. The cells were then washed in 0.1 M sodium cacodylate buffer and postfixed in 1% ferrocyanide-
Immunolocalization of CDH1 and TJP1 in fertile and OA patients. A) Immunolocalization of CDH1 in the epididymis of fertile (a and c) and OA patients (b and d-f). CDH1 (arrowheads) is localized to the apical tight junctional complex and along the lateral margins of epithelial cells, as well as between the basal and principal cells in the corpus epididymidis of (a) fertile patients (n ¼ 3), (b) an OA patient and in the cauda epididymidis of (c) fertile (n ¼ 3) and (d-f) OA (n ¼ 3) patients. In the corpus epididymidis of the OA patient and in the cauda epididymidis of one of the OA patients, the intensity of the signal for CDH1 was higher than that in fertile patients, whereas in the cauda epididymidis of the two other OA patients, the intensity of the signal for CDH1 was weaker than that in fertile patients. Original magnification 3640. B) Immunolocalization of TJP1 in the epididymis of fertile (a and c) and OA (b and d) patients. TJP1 (arrowheads) is localized to the apical tight junctional complex in the corpus epididymidis of (a) fertile (n ¼ 3) and (b) OA (n ¼ 1) patients, as well as in the cauda epididymidis of (c) fertile (n ¼ 3) and (d) OA (n ¼ 3) patients. However, in the corpus epididymidis of the OA patient, the intensity of the signal for TJP1 was higher than that in fertile patients. Original magnification 3640. C) Immunolocalization of VIM, a mesenchymal marker, in the epididymis of fertile (a and c) and OA (b and d) patients. VIM is not expressed in the corpus and cauda epididymidis of fertile patients but is localized in a subset of epithelial cells in the cytoplasm and along their lateral margins in the corpus of an OA patient and in the cauda epididymidis of one of the OA patients. Lu, lumen; IT, interstitial space; P, principal cell; B, basal cell. Original magnification 31600.
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reduced osmium tetroxide, dehydrated in ethanol and propylene oxide, and embedded in EPON (Electron Microscopy Sciences, Hatfield, PA). Thin sections were cut, mounted on copper grids, counterstained with uranyl acetate and lead citrate, and examined for morphology with an FEI Tecnai 12 electron microscope (FEI Company, Hillsboro, OR).
Immunofluorescence
Immunofluorescence labeling of the cells was done to ascertain the epithelial origin of the cells. Rabbit polyclonal anti-cytokeratin (catalog No. 18-0059; Invitrogen Inc.) and mouse monoclonal anti-VIM (catalog No. ab20346; Abcam Inc.) were used. Immortalized cells were grown on plastic chamber slides (Nalge Nunc International) and fixed in methanol at À208C for 10 min. Cells were permeabilized in a solution of 0.3% Triton X-100 in PBS (pH 7.4) for 15 min at room temperature. Cells were then washed in PBS and blocked in the same buffer containing 5% bovine serum albumin for 30 min at 378C, followed by three 5-min washes in PBS. Samples were then incubated with primary antibodies (13.6 lg/ml of cytokeratin or 1 lg/ml of VIM) for 90 min at room temperature and washed three times for 5 min with PBS. Cells were incubated with Alexa Fluor 488 conjugated anti-rabbit or anti-mouse IgG (2 lg/ml; Invitrogen Inc.) for 45 min at 378C. Cells were finally washed three times in PBS and mounted with Vectashield mounting medium containing propidium iodide (Vector Laboratories, Burlington, ON). Sections were examined under a Leica DMRE microscope.
RT-PCR Analysis
The RT reactions were prepared as already described. The PCR was subsequently done to identify the presence of different transcripts in the cell lines using the following amplification protocol: 948C for 5 min, 30-40 cycles of 948C for 30 sec, melting temperature for 30 sec, 728C for 1 min, and cooling to 48C. The sequence of the primers used for differentiation markers is given in Table 2 . Other primers have been previously described by Dubé et al. [24] . The PCR amplicons were separated on an agarose gel (1%-2%) and visualized with ethidium bromide using a Fluor-S Multi-Imager densitometer (Bio-Rad Laboratories, Mississauga, ON). The PCR was also done on RNA that was not reverse transcribed to confirm the absence of genomic DNA. The RNA extracted from human epididymis and kidney (Biochain, Hayward, CA) was used as positive controls.
Cell Cycle Analysis
Immortalized cells were trypsinized, recovered by centrifugation (1000 3 g for 7 min), and washed twice in PBS (pH 7.4). Cells were fixed by resuspending the pellet in ice-cold ethanol and kept on ice for 30 min. The cells were then washed three times in PBS containing 2% FBS. The pellet was finally resuspended in a solution containing 0.1% sodium citrate, 0.3% NP-40, 100 lg/ml of RNase A, and 50 lg/ml of propidium iodide. The DNA content of 2 3 10 6 cells per sample was analyzed using an FACScan apparatus (Becton Dickinson, Oakville, ON). THP1 cells (a kind gift of Dr. D. Girard, INRSInstitut Armand Frappier) were used as control diploid cells as previously shown [37] .
Cell Growth
An aliquot of 1250 immortalized cells per well was plated in 96-well culture plates coated with collagen IV. The number of cells was determined using Trypan blue staining (Invitrogen Inc.) and a hemocytometer. The next day, once the cells had adhered, medium was changed, and this first time point was assigned as time zero. Medium was changed every 24 h. At different time points done in triplicate (0, 24, 48, 120, and 192 h), culture medium was removed from the wells and replaced with 20 ll of methylthiazolyldiphenyltetrazolium bromide (MTT) solution (0.5 mg/ml in culture medium; SigmaAldrich) to measure cellular proliferation [34] . After 3 h, the MTT solution was removed, and the formazan crystals were solubilized with 200 ll of dimethyl sulfoxide per well. The absorbance at 570 nm was read using a microtiter plate reader (Power Wave X; Bio-Tek Instruments Inc., Winooski, VT). The doubling time was calculated as the inverse of the slope of a semilog plot of the absorbance in function of time, in the linear portion of the graph (the logarithmic growth phase). Data are presented as the mean 6 SEM.
Transepithelial Resistance
Cells were seeded at a density of 1 3 10 5 cells/ml on Costar Transwell 6.5-mm cell culture inserts (0.4-lm pore size; Corning, Palo Alto, CA) coated with or without mouse collagen IV (5 lg/cm 2 ; BD Biosciences). The medium used in this experiment was DMEM/HAM F12 culture medium containing antibiotics (50 U/ml of penicillin and 50 lg/ml of streptomycin), 2 mM Lglutamine, and 5% FBS. Once total confluence was reached, cells were exposed to medium containing an additional 1.8 mM CaCl 2 for 48 h, and transepithelial resistance (TER) was measured at regular intervals using an EVOM epithelial voltohmmeter with an STX2 electrode (WPI Inc., Sarasota, FL). TER was normalized to the area of the filter after removal of background resistance of a blank filter that contained only medium. TER was measured as ohms 3 cm 2 . TER measurements were done several times in triplicate. FHCE1 cells derived from the caput epididymidis of a fertile man and shown to form functional tight junctions were used as a positive control [37] . Statistical analyses were performed with two-way ANOVA (significance level set at P 0.05).
Microarray Processing and Analysis
Microarray analysis was done to compare gene expression in infertile human caput epididymal cell line 1 (IHCE1) and fertile HCE1 (FHCE1) cells. Total cellular RNA was isolated using the Illustra RNAspin Mini kit (GE Healthcare, Baie D'Urfe, QC) according to the manufacturer's instructions. The quality of the total RNA was verified using the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). Gene expression profiling was performed with commercially available human oligonucleotide microarrays (20 174 human genes; Agilent Technologies). Analyses were done in triplicate for each cell line. Amplifications and labeling of total RNA (500 ng) were performed using the Low RNA Input Linear Amplification Kit (Agilent Technologies). The cRNA was labeled with either cyanine 3 or cyanine 5 (Perkin Elmer, Woodbridge, ON). Arrays were hybridized according to the manufacturer's instructions using the In Situ Hybridization kit Plus (Agilent Technologies). Following hybridization, microarrays were scanned with a ScanArray Express scanner (Perkin Elmer). Fluorescence ratios for array elements were extracted using the ScanArray Express Software (Perkin Elmer) and imported into GeneSpring 6.1 software (Agilent Technologies) for further analysis. The data were normalized using a locally weighted regression Lowess method. Statistical analyses were performed with one-way ANOVA (significance level set at P 0.05). The data discussed in this publication were deposited in the National Center for Biotechnology Information's (NCBI's) Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/query/ acc.cgi?acc¼GSE21391). Real-time RT-PCR, as described previously, was used to confirm for two genes (PRKCA and CDC42) the differences in transcription that were observed in the microarray analysis.
RESULTS
mRNA Levels for Junctional Proteins in OA Patient
Expression of multiple genes encoding junctional proteins (CDH1, TJP1, CLDN1, CLDN4, CLDN7, and CLDN10) was evaluated in the region of the epididymis downstream of the obstruction in OA patients and compared with approximately the same region in fertile patients (Fig. 1) . Only a single infertile patient was found to have an obstruction in the region of the caput epididymidis. In the corpus epididymidis of this patient, mRNA levels for CLDN1 and CLDN4 were almost twice those of fertile patients (Fig. 1, C and D) , while CLDN10 mRNA levels were decreased by almost 80% (Fig. 1F) . In the cauda epididymidis of OA patients experiencing an obstruction at the level of the corpus, CLDN10 mRNA levels were significantly lower than those observed in the cauda epididymidis of patients with proven fertility (Fig. 1F) . Levels of the other markers were unaltered.
Immunolocalization of Junctional Proteins and VIM
Immunolocalization of CDH1 ( Fig. 2A) in the corpus and cauda epididymidis revealed that CDH1 was localized along the plasma membrane of adjacent principal cells, as well as between basal and principal cells. Some cytoplasmic immunostaining in principal cells was also observed. In the corpus epididymidis of the OA patient, CDH1 was also localized along the lateral margins of adjacent principal cells, as well as between basal and principal cells. The immunoreaction, however, appeared to be more intense in the apical region of 588 DUBE ET AL. [37] . Cells were grown on plastic chambers under identical conditions. ER, endoplasmic reticulum; n, nucleus; v, vesicle; G, Golgi apparatus. Original magnification 316 500-26 500. C and D) Cytokeratin and VIM expression was evaluated by RT-PCR (C) and immunofluorescence staining (D) to assess the epithelial morphology of the cells. Cytokeratin and VIM (green) are expressed and localized to the cytoplasm in all cells lines derived from the infertile patient, whereas only cytokeratin is expressed in the FHCE1 cell line derived from fertile tissue [37] . Nuclei (red) are stained with propidium iodide. Original magnification 3100-400.
EPIDIDYMAL TIGHT JUNCTIONS IN OBSTRUCTIVE AZOOSPERMIA 589 the cells ( Fig. 2A [a and b] ). In the cauda epididymidis of OA patients, CDH1 was not detected in two of three patients ( Fig.  2A [e and f] ). In the third patient, CDH1 was present throughout the cytoplasm, indicating a mistargeting of the protein ( Fig. 2A [d] ).
TJP1 in both the corpus and cauda of patients with proven fertility was localized to the area of the tight junction between adjacent principal cells (Fig. 2B [a and c] ). In the corpus epididymidis of the OA patient, TJP1 was also localized to the area of the tight junctions, although the immunoreaction appeared more intense (Fig. 2B [b] ). In the cauda epididymidis, the immunoreaction for TJP1 was similar in OA patients to that observed in the fertile patients (Fig. 2B [c and d]) .
VIM was not expressed in the corpus and cauda epididymidis of fertile patients (Fig. 2C [a and c] ). However, it was localized in a small subset of epithelial cells in their cytoplasm and along their lateral margins in the corpus of an OA patient (Fig. 2C [b] ) and in the cauda epididymidis of OA patients (Fig. 2C [d] ).
Human Epididymal Cell Lines
Cell lines were derived from the caput epididymidis of a 27-yr-old man with OA (patient 10 in Table 1 ). The obstruction was localized to the proximal area of the caput epididymidis. Five separate cells lines (IHCE1, IHCE2, IHCE3, IHCE4, and IHCE5) were derived from the tissue obtained from this patient. Ultrastructural analysis of each cell line indicated that these are composed of epithelial principal cells. The cells have characteristic microvilli or stereocilia on their cell surface, a large and irregular nucleus, endosomal elements, and mitochondria (Fig. 3A) . The cells derived from the infertile patient appeared more flattened and possessed fewer less developed organelles than the cells previously derived from a fertile patient (Fig. 3B) . The cell lines express cytokeratin (an epithelial cell marker) and VIM (a mesenchymal marker) at both the mRNA and protein level (Fig. 3, C and D) . These results indicate that the immortalized epididymal cell lines originate from principal-like cells but appear to be somewhat partly dedifferentiated, as suggested by the expression of VIM. Furthermore, the cells (which have been passed !20 times) are diploid ( Fig. 4A) and have a doubling time of approximately 7-11 days (Fig. 4B) . These represent the first stable epididymal cell lines to be derived from the adult epididymis of an infertile patient.
Characterization of Human Epididymal Cell Lines
The RT-PCR was used to verify the expression of several differentiation and epididymal markers in the cell lines. Most of the transcripts encoding retinoic acid and thyroid hormone receptors were detected in the cell lines with the exception of RARB and THRB (Fig. 5A) . The expression of these markers was also evaluated in the FHCE1 cell line derived from the caput epididymidis of a fertile patient [37] . Among the epididymal markers, only SPAG11B (also known as HE2) was expressed in the cell lines derived from the infertile patient (Fig. 5B) . The expression of SLC9A3, an Na þ /H exchanger also known as NHE3 that has been shown to be expressed in the epithelium of the human efferent ducts but not in the epididymis [35] , was verified using RNA from human kidney [36] as a positive control. NHE3 was not expressed in any of the cell lines, thereby confirming that these cells were not of efferent duct origin (Fig. 5B) . Transcripts for the androgen (AR), estrogen receptors (ESR1 and ESR2), and 5-alphareductase enzymes (SRD5A1 and SRD5A2) were also determined in each cell line (Fig. 5C ). Only AR was expressed in IHCE1 and IHCE2 cell lines. Overall, our cell lines from infertile patients retained some of the differentiated functions that characterize in vivo principal cells but not as many as the FHCE1 cell line developed from the caput epididymidis of a fertile patient [37] . 
mRNA Levels of Genes Encoding for Junctional Proteins
Transcript levels of genes encoding different junctional proteins implicated in adherens (CDH1 and CDH2), tight junctions (CLDN1, CLDN2, CLDN3, CLDN4, CLDN7, and CLDN8), and desmosomes (desmoplakin [DSP]) were assessed (Fig. 6A) . With the exception of CLDN2, CLDN3, and DSP, these transcripts were not expressed in the cell lines derived from the infertile patient.
Formation of Tight Junctions by IHCE1 Cells
The ability of IHCE1 cells to form functional tight junctions was assessed. Epididymal tight junctions are necessary for the formation of the blood-epididymis barrier and for sperm maturation. TER was used to measure the formation of tight junctions in calcium-stimulated cells (Fig. 6B) . Cells derived from the caput epididymidis of a fertile patient were used as a positive control [37] . There was no increase in TER measured in IHCE1 cells, indicating that these cells are not capable of forming tight junctions. Similar results were observed with cells seeded on inserts coated with mouse collagen IV (data not shown).
Differential Gene Expression in IHCE1 and FHCE1 Cell Lines
Microarray analyses were used to compare gene expression profiles in IHCE1 and FHCE1 cells in order to identify potential key elements implicated in the formation, maintenance, and/or regulation of human epididymal tight junctions. Arrays were hybridized with probes of each cell line to identify genes that were either downregulated or upregulated in IHCE1 cells compared with FHCE1 cells. The data discussed in this publication have been deposited in NCBI's GEO (http://www. A) The expression of RARB and THRB was reduced in the cell lines derived from the epididymis of the infertile patient compared with the FHCE1 cell line derived from fertile tissue [37] . B) SPAG11B was expressed in the different cell lines derived from infertile tissue, while no band was detected for CRISP1, SPINLW1, NPC2, DCXR, or SLC9A3. C) AR was expressed in the IHCE1 and IHCE2 cell lines, while ESR1, ESR2, SRD5A1, and SRD5A2 were not detected in any of the cell lines. Neg, negative control; Pos, positive control; Epid, epididymis.
FIG. 6. Tight junctions in the different cell lines.
A) Expression of genes encoding tight junctional proteins by RT-PCR. Expression of the different transcripts was verified using specific primers. Human epididymis was used as a positive control. Only CLDN2, CLDN3, and DSP were expressed in the different cell lines derived from infertile tissue. B) TER was measured in IHCE1 cells at different time points after switching from low to normal calcium containing medium with an additional concentration of 1.8 mM (n ¼ 3, 6 SEM). Results shown are from a representative experiment that was repeated at least three times. No peak in TER was seen after calcium switch, in contrast to FHCE1 cells [37] . *P , 0.05 versus IHCE1, ***P , 0.001 versus IHCE1. Neg, negative control; Epid, epididymis.
EPIDIDYMAL TIGHT JUNCTIONS IN OBSTRUCTIVE AZOOSPERMIA ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼GSE21391) and are accessible through GEO Series accession number GSE21391. In these analyses, 2958 genes were differentially expressed in IHCE1 cells by at least a 2-fold change compared with FHCE1 cells: 1567 genes were downregulated and 1391 upregulated. Among them, 705 genes were downregulated and 312 genes upregulated by at least a 4-fold change (Fig. 7A) . Two of the genes, CDC42 and PRKCA, were selected for real-time RT-PCR analysis to validate the microarray data. Expression patterns showed consistency between microarrays and realtime RT-PCR analysis (Fig. 7B) . Most of the genes that were differentially regulated, and for which a function was known, encoded proteins implicated in transport (electrons, ions, water, and other), signal transduction (including G-proteins and MAPK pathways), and protein metabolism, transport, targeting, and transcription. Several genes also encoded proteins implicated in apoptosis, cell adhesion and junctions, cell morphogenesis and differentiation, cell growth and proliferation, cell motility, cytoskeleton organization and biogenesis, and immunity (Fig. 7C) . Further analyses were done on genes known to be implicated in the formation of cellular junctions (Table 3) . Several genes encoding cadherins (CDH24), protocadherins (PCDHGA8, PCDH18, CDHR2, PCDHB11, CDHR5, and PCDHB13), and catenins (CTNNB1 and CTNNBIP1) were upregulated in IHCE1 cells compared with FHCE1 cells by at least a 1.5-fold change. Several genes encoding connexins (GJC1, GJB4, and GJC2), pannexin-3 (PANX3), and CLDNs (CLDN9, CLDN11, CLDN17, and CLDN18) were also upregulated by at least a 1.5-fold change in IHCE1 cells compared with FHCE1 cells. Genes that were downregulated by at least a 1.5-fold change in IHCE1 cells were compared with FHCE1 cells and included N-cadherin (CDH2) and two catenins (CTNNA1 and CTNNAL1). Further analyses were done on genes that have been shown in other cell types to be implicated in the regulation of cellular junctions (Table 4 and Table 5 ). Genes that were upregulated by at least a 1.5-fold change in IHCE1 cells compared with FHCE1 cells (Table 4 ) included genes that encoded several transcription factors such as the CLDN repressor Slug (SNAI2), members of the Ras protein family (RAB36, RAB2, RAB10, RAB21, RAP1A, RAP1B, HRAS, RRAS2, RHOA, and RHOG), oncogenes (MOS, CSK, NOTCH3, NOTCH2, JUNB, and JUND), protein kinases and their binding proteins (PRKCA, PRKCD, and PRKCDBP), MAPK family member MAP2K3, integrin-mediated signaling pathway member ILK, members of the APC/Wnt signaling pathway (APC, APC2, WNT2, and WIF1), members of the JAK-STAT signaling pathway (JAK1 and JAK3), and members of the frizzled gene family (FZD5, FZD1, and FZD2). Genes that were downregulated by at least a 1.5-fold change in IHCE1 cells compared with FHCE1 cells ( Table 5 ) included genes that encoded oncogenes (JUN and MYC), protein kinases (PRKAG2, PRKCZ, and PRKAR1A), MAPK family member MAP2K2, members of the Ras protein family (RAB34, RAB18, RAB22A, RAB32, RAB13, RHOC, CDC42, and RAC1), and Wnt family member DVL1.
Several other genes that have been shown to be expressed in the epididymis were differentially regulated in IHCE1 cells compared with FHCE1 cells by at least a 1.5-fold change (Table 6 ). Upregulated genes included WFDC2 (also known as HE4), AKAP1, AQP5, ADAMTS10, ADAM19, and ADAM15, while downregulated genes comprised cathepsins (CTSZ and CTSB), DCXR (also known as P34H), and MIF.
DISCUSSION
We have previously shown that epididymal gene expression and the blood-epididymis barrier are altered in non-OA patients [15] . In the present study, we report that in patients with OA and in epididymal cell lines derived from OA patients, components of the adherens and tight junctions of the epididymis are altered, thereby supporting the notion that the blood-epididymis barrier is altered in infertile patients. Given the low fertility rates of patients following epididymovasostomy to circumvent epididymal obstruction [7, 8, 38] , these data suggest that epididymal function also needs to be considered in these infertile patients.
The expression of several genes encoding tight junctional proteins (CLDN1, CLDN4, and CLDN10) was altered in the corpus epididymidis of an OA patient, while only CLDN10 expression was altered in the cauda epididymidis of OA patients. These results suggest that the site of the obstruction has an impact on the level of alteration of the blood-epididymis barrier in OA patients. Rajalakshmi et al. [39] have previously reported the occurrence of degenerative changes in the epididymis of OA patients and observed that these were less pronounced when the site of the obstruction was situated more distally in the epididymis. In addition, our immunolocalization of CDH1, TJP1, and VIM revealed some differences between OA and fertile patients. These results suggest that both the barrier and the paracellular transport, as well as adherens junctions, are affected in the epididymis of OA patients. Moreover, it is notable that both TJP1 and CLDN10 are affected in OA and non-OA patients [15] . This suggests that the expression of these two genes may be regulated by testicular factors that are released into the lumen of the epididymis. Previous investigators have also reported that CLDN10 mRNA levels in the corpus epididymidis are decreased in patients with vasectomy [40] . Whether or not this is also associated with movement of factors in the luminal fluid from the testis toward the corpus epididymidis is unknown. However, it would appear that CLDN10 is particularly sensitive to changes in the lumen environment of the epididymis.
The limited ability to obtain epididymal tissues from infertile patients has greatly hindered the ability to assess the role of the epididymis in male infertility. The development of cell lines that maintain characteristics similar to those found in infertile patients represents a tremendous potential to address cellular and molecular mechanisms of epididymal function in infertile patients. The different cell lines developed in this study retain some of the characteristics of in vivo principal cells. These cells have an ultrastructure similar to epididymal principal cells and similar to cell lines derived from the epididymidis of a fertile patient [37] , are diploid, and are not from the efferent ducts, as confirmed by absence of SLC9A3 expression [35] .
The cell lines lack the expression of several epididymal (SPINLW1, CRISP1, NPC2, CD52, and DCXR) and differentiation (RARB and THRB) markers, suggesting that these cells may be undergoing epithelial-mesenchymal transition (EMT) [41] . This was not the case in FHCE1 epididymal cell lines derived from the caput epididymidis of a fertile patient, which express NPC2, SPAG11B, CD52, and DCXR [37] . The expression of RARB and THRB is frequently reduced in cancerous cells that undergo EMT [42, 43] . This is also suggested by the flattened aspect of the cells and the paucity of organelles, which has also been previously observed in the vas deferens epithelium of patients following vasectomy [44] . Furthermore, the epididymal cell lines also express both cytokeratin and VIM, a mesenchymal marker. VIM was also expressed by a small subset of epithelial cells in the epididymis of OA patients, suggesting that a small percentage of epithelial cells could be less differentiated in these tissues and may represent the origin of the cell lines developed in this study. Previous studies have shown that obstruction in the caput epididymidis can lead to extensive degenerative ultrastructural changes in the principal cells of the caput epididymidis due to abnormal fluid reabsorption [39] , leucocytic infiltration [45] , and high levels of antisperm antibodies [14] . Obstruction as a consequence of vasectomy has also been shown to affect the osmolarity and composition of epididymal intraluminal fluid [46] . All of these changes are consistent with alterations to the blood-epididymis barrier.
IHCE1 cells lack the ability to form tight junctions due to the absence or low expression levels of several genes encoding junctional proteins (CDH1, CDH2, CLDN1, CLDN3, CLDN4, CLDN7, and CLDN8). Indeed, CLDN1, CLDN3, CLDN4, and CLDN7 have been reported to be important for the integrity of human epididymal tight junctions [37] . Thus, our present results are not surprising because EMT is characterized by the disassembly of junctional structures [41] . In addition, many functions in the proximal epididymis are regulated by lumicrine factors, including the expression and localization of several junctional proteins (such as CLDN1 and CLDN8) in 594 rodents [26, 47] . This could explain why the effects are greater following an obstruction in the proximal caput epididymidis compared with other epididymal regions. In addition, the absence (or low level of expression) of AR, SRD5A isoforms, and ER in the majority of our cell lines derived from the infertile patient suggests that the cells have limited ability to respond to androgens and estrogens.
There is surprisingly limited information about the hormones and intracellular signaling pathways implicated in the formation and maintenance of the blood-epididymis barrier [23] . Because the IHCE1 cells do not form functional tight junctions, we compared gene expression profiles with human epididymal principal cells (FHCE1) that were derived from a fertile patient and were shown to form functional tight junctions, in order to identify regulatory pathways that may be implicated in the regulation of epididymal tight junctions [37] . Several differentially expressed genes that encode junctional proteins such as cadherins, protocadherins, catenins, connexins, and pannexin-3 were all shown to have different expression levels between IHCE1 and FHCE1 cells, suggesting that cell adhesion and cell communication may be impaired in OA. The EMT process implicates signaling pathways such as growth factors (Wnt, Notch, and others) that can induce EMT and act in a sequential manner [41] . In addition, several transcription factors (such as SNAI1 [Snail] , SNAI2 [Slug] , and TWIST) have been shown to be responsible for the downregulation of genes (CDHs, CLDNs, connexins, OCLN, and TJPs) that contribute to the assembly of junctional complexes [48] . Many of these effectors were upregulated in IHCE1 cells. In addition, other players important for the assembly of cell junctions [49] (such as RAB13, CDC42, and PKC isoforms) are downregulated in IHCE1 cells. These results suggest that the regulation of cellular junctions that participate in the creation and maintenance of the human blood-epididymis barrier may be altered in OA. Furthermore, these data suggest that this regulation is accomplished via a variety of signaling pathways as opposed to a single pathway (Fig. 8) .
The study of signaling pathways in the epididymis of fertile and infertile patients is necessary to better understand the importance of each pathway in the regulation of human epididymal junctions. The role of these effectors can vary according to the cell type [49] , and several of these may be involved in sperm maturation. For example, haploinsufficiency of the PRKAR1A gene is associated with reduced male fertility [50] . In addition, previous investigations have demonstrated that epididymal obstruction can disrupt the secretory activities of the epididymal epithelium [46] . For example, reduced expression of DCXR (also known as P34H), which has been associated with male infertility, is observed as a consequence of vasectomy [51, 52] , and its expression is not always restored after vasectomy reversal [53] . Several cathepsins are also downregulated, and it has been shown in rodents that absence or low expression of specific cathepsins is associated with reduced male fertility [54, 55] .
Our study has identified alterations in the expression of epididymal markers and components of cellular junctions in the epididymis of infertile OA patients. Azoospermia due to epididymal obstruction could involve multiple epididymal defects, including an altered blood-epididymis barrier, impaired cell adhesion, and affected communication and differential expression of epididymal markers. However, the impact of the obstruction on epididymal structure and/or function probably varies according to the cause, location, and duration of obstruction. Overall, these alterations could also explain why fertility is not restored in all patients after epididymovasostomy [38] . Clearly, our data suggest that as a result of altered gene expression to critical transport and junctional proteins, the luminal environment of the epididymis is unlikely to be optimal for sperm maturation and survival after surgical reconstruction. These results support the notion that the epididymis is affected in male infertility and that epididymal function needs to be considered in surgical procedures aimed at improving fertility in OA patients.
